Navigation Links
Aortic aneurysm treatable with asthma drugs
Date:11/16/2010

A new study from the Swedish medical university Karolinska Institutet shows that asthma drugs are a potential treatment for aortic aneurysm. These drugs, which block cysteinyl-leukotrienes, could reduce the break down of vessel wall tissue and the dilation of the aortic wall, and thus the risk of its rupturing. This could both save lives and reduce the need for complicated and risky surgery. The results are presented in the scientific journal PNAS.

Aortic aneurism is a life-threatening disease caused by the weakening of a section of the wall of the aorta, which then dilates and, in advanced cases, risks rupturing. If the condition is discovered in time, surgery is a possible course of action, but often the disease develops unnoticed, causing death by sudden and massive internal haemorrhage when the aneurysm bursts.

Aortic aneurysms are more common in the 65-plus age group, and amongst men. One of the causes of the disease is a chronic inflammatory, multi-signal molecule process which activates enzymes that slowly break down proteins and the various components of the vessel wall tissue. This promotes the development of the disease and the eventual rupture of the aorta.

Researchers at Karolinska Institutet have now discovered that the wall of an aortic aneurysm contains increased levels of enzymes able to form what scientists call cysteinyl-leukotrienes. As these biologically potent substances trigger the contraction of smooth muscle and a swelling of the airways they can cause asthma, and therefore asthma patients are often treated with drugs that block cysteinyl-leukotrienes.

"We've also found that cysteinyl-leukotrienes can stimulate the release of protein-digesting enzymes called metalloproteases, which can contribute to the weakening of the aortic wall and the development of an aneurysm," says Professor Jesper Haeggstrm, who led the study.

The researchers found that the introduction of an asthma drug blocked the cysteinyl-leukotrienes and thus impeded the release of the harmful metalloproteases. Their results suggest that this type of asthma drugs could be used to reduce aortic dilation and hence the danger of a ruptured aneurysm.

"These asthma drugs are both efficacious and safe, and we should soon be able to test any positive effect they might have on aortic aneurysm," says Professor Jesper Haeggstrm.


'/>"/>

Contact: Katarina Sternudd
katarina.sternudd@ki.se
46-852-483-895
Karolinska Institutet
Source:Eurekalert

Related medicine news :

1. Clinical trial establishes catheter-based aortic valve replacement as new standard of care
2. New treatment for severe aortic stenosis shown to save lives, Stanford researchers say
3. New Procedure for Aortic Valve Replacement Looks Promising
4. Amphetamine use increases risk of aortic tears in young adults, UT Southwestern researchers report
5. Regional protocols improve quality of care for aortic dissection patients
6. Less Invasive Fix for Abdominal Aortic Aneurysm Works
7. Research team documents benefits of endovascular stent repair for traumatic aortic injury
8. Scott & White Memorial Hospital uses device to revolutionize treatment of traumatic aortic injury
9. Oral contraceptives and hormone replacement therapy may protect women against brain aneurysms
10. Early Detection Makes a Difference in the Treatment of Brain Aneurysms
11. Cedars-Sinai study examines regional use of minimally invasive repair of aneurysms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... ... September 25, 2017 , ... G-CON Manufacturing, ... Miniature, and Modular (PCMM) collaboration with Pfizer and GEA by designing and building ... The new PODs will provide tablet coating capability in the existing line at ...
(Date:9/25/2017)... ... September 25, 2017 , ... International Water Advocate Sharon ... Kleyne Hour Power of Water, Global Climate Change and Your Health on VoiceAmerica ... from a once-every-four-years series of events to a personal, daily Health Olympics. “Wouldn’t ...
(Date:9/25/2017)... ... September 25, 2017 , ... METTLER TOLEDO is pleased ... 25-26, 2017 in Los Angeles, CA. The symposium will feature speakers from North American ... today's mass calibration technologies and help with planning for the future of the modern ...
(Date:9/25/2017)... ... September 25, 2017 , ... Physician Partners of America ... at 5304 Main Street as an interventional pain management specialist. , Dr. Gorman ... He joins PPOA from private practice In Brooksville, Fla. His orthopedic background puts him ...
(Date:9/25/2017)... ... 25, 2017 , ... Earlypicker is expanding its offerings to include fashion, a ... Korean cosmetics and fashion trends sweeping the nation. The decision to expand beyond Korean ... great offerings that allow Koreans everywhere to look their best every single day. , ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... INDIANAPOLIS , Sept. 7, 2017  Eli ... today announced actions to streamline operations to more ... to improve its cost structure. Global workforce reductions, ... program, are expected to impact approximately 3,500 positions. ... the company expects annualized savings of approximately $500 ...
(Date:9/7/2017)... Sept. 7, 2017   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade cell and tissue hypothermic storage ... Mike Rice , President and CEO, will be presenting ... Rodman & Renshaw 19 th Annual Global Investment ... (12:25 p.m. Pacific time). The conference is being held at ...
(Date:9/6/2017)... Eli Lilly and Company (NYSE: ... for galcanezumab and lasmiditan, two investigational treatments for migraine, ... (IHC) taking place Sept. 7-10 in Vancouver ... long-term data from an open-label study evaluating the safety ... and 240 mg) for the prevention of migraine. Galcanezumab ...
Breaking Medicine Technology: